Blood-brain barrier-traversing multivalent TGFβ trap for anti-cancer immunomodulation of gliomas
Clinical studies have revealed that glioblastoma (GBM) is refractory to immunotherapy, such as immune checkpoint inhibitors (ICIs), due to the immunosuppre